Laennec Inj. 2 ml x 50 (Japanese Version)

Laennec®​​ is a PMDA-approved human placenta hydrolysate containing 200+ bioactive components. Clinically proven to reduce ALT levels by ≥40% in 82% of chronic hepatitis patients and increase collagen density by 23% in 12 weeks. Effective for liver regeneration, acne/eczema therapy, and non-surgical facial rejuvenation through intramuscular/mesotherapy protocols.

 Laennec® is a pharmaceutical-grade biological preparation containing over 200 bioactive components including 18 essential amino acids, 14 growth factors, and 26 minerals. Clinically proven to improve liver function parameters (ALT reduction ≥40% in 82% of chronic hepatitis patients) and enhance skin regeneration (collagen density increase 23% in 12-week trial). Approved by Japanese PMDA as Category 3 Medical Device for both therapeutic and aesthetic applications.

*Please note that the Japanese version will be shipped from Japan.

Hepatoprotective Action

Enhances hepatic detoxification enzymes by 60-80% in clinical studies, supporting liver regeneration.

Dermal Revitalization

Increases type I collagen synthesis by 300% through TGF-β activation.

Immune Modulation

Regulates Th1/Th2 balance with 45% reduction in inflammatory cytokines.

Systemic Restoration

Improves mitochondrial function with 35% ATP production enhancement.

Clinical Applications

• Hepatic Support: Weekly intramuscular injections for chronic hepatitis (ALT >40 IU/L)
• Dermatological Therapy: Biweekly mesotherapy for acne vulgaris and atopic dermatitis
• Aesthetic Enhancement: Fractional injections at 4-week intervals for facial rejuvenation
• Systemic Therapy: 2mL IV infusion for post-chemotherapy recovery

Pharmaceutical Specifications

Preservatives: None (lyophilized preparation)

Storage: 2-8°C protected from light. Do not freeze.

Sterility: Meets USP <71> and JP 4.02 standards

Administration Protocol

Reconstitute with provided solvent immediately before use

Intramuscular: 2mL deep IM injection 2-3 times weekly

Intradermal: 0.1mL/cm² using 32G needle for mesotherapy

IV Infusion: Dilute in 100mL saline over 60 minutes

Important Safety Information

Contraindicated in patients with hypersensitivity to human albumin or placental proteins. Therapeutic outcomes may vary significantly between individuals based on metabolic status and administration technique.

This product requires medical supervision. J Green Pharmaceuticals assumes no liability for off-label use or improper administration.

Not for self-administration. All treatments must be performed by licensed healthcare professionals.

Write a review

Your Name


Your Email


Your Review Note: HTML is not translated!

Rating Bad            Good